Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | RVTY | HQY | ||
| Company | Charles River Laboratories | Revvity Inc | Healthequity | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 230.23 | 113.14 | 95.46 | ||
| High | 231.98 | 113.81 | 95.54 | ||
| Low | 225.03 | 110.25 | 94.32 | ||
| Latest | 226.58 | 110.47 | 94.64 | ||
| Change | -2.71 | -2.70 | +0.31 | ||
| % Change | -1.18% | -2.39% | +0.32% | ||
| Volume | 476,100 | 1,117,800 | 973,700 | ||
| 20-Day Average Volume | 879,600 | 1,436,500 | 908,295 | ||
| Previous Close | 229.29 | 113.17 | 94.33 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 226.77 | 111.42 | 94.74 | ||
| 20-Day Raw Stochastic | 57.47% | 58.75% | 67.03% | ||
| 20-Day Relative Strength | 61.08 | 55.10 | 55.40 | ||
| Weighted Alpha | +37.96 | +14.34 | +3.75 | ||
| Today's Opinion | 72% Buy | 64% Buy | 72% Buy | ||
| Previous Opinion | 88% Buy | 80% Buy | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 72% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.99% since 07/17/26 | +0.29% since 07/17/26 | -3.11% since 07/17/26 | ||
| Low | 213.40 on 07/21/26 | 102.36 on 07/21/26 | 93.70 on 07/23/26 | ||
| High | 238.85 on 07/23/26 | 116.00 on 07/23/26 | 99.43 on 07/20/26 | ||
| 1-Month | |||||
| %Chg | +12.11% since 06/24/26 | +4.58% since 06/24/26 | +11.34% since 06/24/26 | ||
| Low | 202.78 on 06/25/26 | 102.36 on 07/21/26 | 83.10 on 06/25/26 | ||
| High | 238.85 on 07/23/26 | 116.16 on 06/26/26 | 100.00 on 07/17/26 | ||
| 3-Month | |||||
| %Chg | +33.44% since 04/24/26 | +27.31% since 04/24/26 | +14.78% since 04/24/26 | ||
| Low | 146.20 on 05/19/26 | 81.22 on 04/29/26 | 79.36 on 04/30/26 | ||
| High | 238.85 on 07/23/26 | 116.16 on 06/26/26 | 100.00 on 07/17/26 | ||
| 6-Month | |||||
| %Chg | +3.17% since 01/23/26 | -5.36% since 01/23/26 | +12.51% since 01/23/26 | ||
| Low | 146.20 on 05/19/26 | 81.22 on 04/29/26 | 72.76 on 02/17/26 | ||
| High | 238.85 on 07/23/26 | 118.21 on 01/26/26 | 100.00 on 07/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,913,904 | 12,324,032 | 7,911,675 | ||
| Shares Outstanding, K | 48,168 | 111,560 | 83,602 | ||
| Annual Sales | 4,015,380,000 | 2,856,050,000 | 1,313,430,000 | ||
| Annual Net Income | -144,340,000 | 241,200,000 | 215,200,000 | ||
| Last Quarter Sales | 995,830,000 | 711,120,000 | 354,640,000 | ||
| Last Quarter Net Income | -14,840,000 | 40,720,000 | 69,420,000 | ||
| 60-Month Beta | 1.40 | 1.09 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.06 on 05/07/26 | 1.06 on 05/05/26 | 1.24 on 05/28/26 | ||
| Earnings Date | 08/05/26 | 08/04/26 | 09/01/26 | ||
| Most Recent Dividend | N/A | 0.070 on 07/17/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/17/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 22.93 | 22.10 | 26.28 | ||